Clinical Trial Design in Alzheimer's Disease
Our understanding of Alzheimer's disease (AD) has drastically improved during the past decade as multiple large-scale studies have been implemented. These studies try to provide a large data set of markers and characteristics of patients with AD. The complexity of these factors and the disease...
Main Authors: | Seyed Mehrdad Savar, Niayesh Mohebbi |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center for Rational Use of Drugs (RCRUD)
2022-06-01
|
Series: | Journal of Pharmaceutical Care |
Subjects: | |
Online Access: | https://jpc.tums.ac.ir/index.php/jpc/article/view/504 |
Similar Items
-
Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
by: Marina Ritchie, et al.
Published: (2023-11-01) -
Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
by: Marina Ritchie, et al.
Published: (2023-02-01) -
Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China
by: Yuxia Cao, et al.
Published: (2022-11-01) -
Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trials
by: Kathy Y. Liu, et al.
Published: (2021-01-01) -
Avoiding future controversies in the Alzheimer’s disease space through understanding the aducanumab data and FDA review
by: Samuel P. Dickson, et al.
Published: (2023-05-01)